These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18076712)

  • 1. Cervical thymic hyperplasia after chemotherapy in an adult patient with Hodgkin lymphoma: a potential cause of false-positivity on [18F]FDG PET/CT scanning.
    Fallanca F; Giovacchini G; Ponzoni M; Gianolli L; Ciceri F; Fazio F
    Br J Haematol; 2008 Mar; 140(5):477. PubMed ID: 18076712
    [No Abstract]   [Full Text] [Related]  

  • 2. A rare case of primary thymic Hodgkin lymphoma in an elderly patient detected by 18F-FDG PET/CT.
    Treglia G; Lococo F; Petrone G; Stefanelli A; Carnassale G; Calcagni ML; Granone P; Giordano A
    Clin Nucl Med; 2013 May; 38(5):e236-8. PubMed ID: 23377412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False positivity of FDG-PET/CT in a child with Hodgkin disease.
    Beker DB; Berrak SG; Canpolat C; Tugtepe H; Ones T; Tecimer T
    Pediatr Blood Cancer; 2008 Apr; 50(4):881-3. PubMed ID: 17417791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases.
    Molin D; Hagberg H; Suurküla M; Aström G
    Acta Oncol; 2010 May; 49(4):526-8. PubMed ID: 20397779
    [No Abstract]   [Full Text] [Related]  

  • 5. False positivity of FDG-PET during hemophagocytic lymphohistiocytosis in a child with Hodgkin lymphoma in remission.
    Corapcioglu F; Oncel S; Berberoğlu K; Klç SC; Aydoğan A; Doğan S
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):74-5. PubMed ID: 19125095
    [No Abstract]   [Full Text] [Related]  

  • 6. FDG-PET response-adapted therapy: is 18F-fluorodeoxyglucose positron emission tomography a safe predictor for a change of therapy?
    Hutchings M
    Hematol Oncol Clin North Am; 2014 Feb; 28(1):87-103. PubMed ID: 24287070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
    Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
    Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [FDG-PET in Hodgkin lymphoma].
    Kobe C; Dietlein M; Mauz-Körholz C; Engert A; Borchmann P; Sabri O; Schober O; Schicha H; Kluge R
    Nuklearmedizin; 2008; 47(6):235-8; quiz N75-6. PubMed ID: 19057796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic hyperplasia following chemotherapy in adults with lymphoma: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings and correlation with T cell repopulation.
    Sun DP; Ding CY; Wang L; Liang JH; Fan L; Wu YJ; Tian T; Li TN; Xu W; Li JY
    Leuk Lymphoma; 2015; 56(8):2344-9. PubMed ID: 25407653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strange case of phyllodes tumor detected using (18)F-FDG PET/CT in an adolescent patient affected by Hodgkin lymphoma: a possible pitfall.
    Cucinotta M; Quartuccio N; Coppolino P; La Delfa V; Bianchi M; Fagioli F; Cistaro A
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):e201-5. PubMed ID: 25240649
    [No Abstract]   [Full Text] [Related]  

  • 11. Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma.
    Franke FC; Damek A; Steglich J; Kurch L; Hasenclever D; Georgi TW; Wohlgemuth WA; Mauz-Körholz C; Körholz D; Kluge R; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlen J; Fernández-Teijeiro A; Cepelova M; Klekawka T; Attarbaschi A; Ceppi F; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Moellers M; Buerke B; Stoevesandt D
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30421. PubMed ID: 37243889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic extension in the superior mediastinum in patients with thymic hyperplasia: potential cause of false-positive findings on 18F-FDG PET/CT.
    Smith CS; Schöder H; Yeung HW
    AJR Am J Roentgenol; 2007 Jun; 188(6):1716-21. PubMed ID: 17515398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
    El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic status-dependent thymic changes on 18F-FDG PET/CT in an adult patient with lymphoma who underwent 2 phases of chemotherapy.
    Fan Q; Su M; Li L; Li F; Tian R
    Clin Nucl Med; 2014 Mar; 39(3):e243-5. PubMed ID: 24300345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.
    Kostakoglu L; Goldsmith SJ; Leonard JP; Christos P; Furman RR; Atasever T; Chandramouly A; Verma S; Kothari P; Coleman M
    Cancer; 2006 Dec; 107(11):2678-87. PubMed ID: 17063502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease.
    Small EJ; Venook AP; Damon LE
    Cancer; 1993 Aug; 72(3):905-8. PubMed ID: 8334644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: preliminary results of a prospective study.
    Paolini R; Rampin L; Rodella E; Ramazzina E; Banti E; Al-Nahhas A; Rubello D
    Nucl Med Rev Cent East Eur; 2007; 10(2):87-90. PubMed ID: 18228212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
    von Falck C; Rosenthal H; Gratz KF; Galanski M
    Clin Nucl Med; 2007 Aug; 32(8):640-2. PubMed ID: 17667441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas.
    Kostakoglu L
    Clin Lymphoma Myeloma; 2008 Oct; 8(5):273-6. PubMed ID: 18854280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.